SCHEMBL24673909

SCHEMBL24673909

ONc1ccccc1CBr

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.35
▸ TSHR P16473 2/20 0.35
▸ IDO1 P14902 2/20 0.35
▸ TRPA1 O75762 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HDAC3 O15379 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC7 Q8WUI4 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC10 Q969S8 1/20 0.33
▸ HDAC11 Q96DB2 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ HDAC9 Q9UKV0 1/20 0.33
▸ HDAC5 Q9UQL6 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21930796 0.79 TDP1 (0.41) CA12CA2CA9ALDH1A1TSHR
SCHEMBL31112260 0.76 L3MBTL1 (0.43) CA12CA2CA9ALDH1A1TSHR
SCHEMBL2255093 0.76 ALDH1A1 (0.53) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL23734263 0.76 GABRA1 (0.52) CA12CA2CA9ALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL9527681 0.74 ALDH1A1 (0.52) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL3530917 0.74 L3MBTL1 (0.49) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL1506234 0.73 L3MBTL1 (0.56) ALDH1A1IDO1L3MBTL1HDAC8HDAC6
SCHEMBL9413635 0.73 ADRA2B (0.44) CA12CA2CA9ALDH1A1HDAC3
SCHEMBL14141191 0.73 TAAR1 (0.54) CA12CA2CA9CYP2D6MEN1
SCHEMBL10699803 0.73 AR (0.43) CA12CA2CA9ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4067355-A1 SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYME (DUB) INHIBITORS Mission Therapeutics Limited (GB) 2022-10-05 — — EP disclosed
Send feedback